Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy.

MLA

Mhatre, Ketaki N., et al. “Crosstalk between FGF23- and Angiotensin II-Mediated Ca2+ Signaling in Pathological Cardiac Hypertrophy.” Cellular & Molecular Life Sciences, vol. 75, no. 23, Dec. 2018, pp. 4403–16. EBSCOhost, https://doi.org/10.1007/s00018-018-2885-x.

APA

Mhatre, K. N., Wakula, P., Klein, O., Bisping, E., Völkl, J., Pieske, B., & Heinzel, F. R. (2018). Crosstalk between FGF23- and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy. Cellular & Molecular Life Sciences, 75(23), 4403–4416. https://doi.org/10.1007/s00018-018-2885-x

Chicago

Mhatre, Ketaki N., Paulina Wakula, Oliver Klein, Egbert Bisping, Jakob Völkl, Burkert Pieske, and Frank R. Heinzel. 2018. “Crosstalk between FGF23- and Angiotensin II-Mediated Ca2+ Signaling in Pathological Cardiac Hypertrophy.” Cellular & Molecular Life Sciences 75 (23): 4403–16. doi:10.1007/s00018-018-2885-x.